Recent Press: Both Serious and Not
Kemp Dolliver, CFA
Senior Analyst/Director of Research at Brookline Capital Markets
We've been mentioned in two publications recently on two completely different subjects.
One is serious:
Down More Than 30%, Biosimilar Stocks Still Aren’t Healthy for Investors
The other is not:
A Sports Column Goes to the Hogs
There's no bad publicity except an obituary.
Brendan Behan